Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wade Berrettini

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 7, 2005
Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's diseaseSara M Bodner, Wade Berrettini, Vivianna van Deerlin, et al.
BMC Neuroscience|March 11, 2010
Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependenceJay Jin, Saranya Kittanakom, Victoria Wong, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 6, 2007
Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trialRiju Ray, Christopher Jepson, E Paul Wileyto, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trialsCaryn Lerman, Christopher Jepson, E Paul Wileyto, et al.
Psychiatric Genetics|December 31, 2010
Genetic association of bipolar disorder with the β(3) nicotinic receptor subunit geneSarah M Hartz, Peng Lin, Howard J Edenberg, et al.
Drug and Alcohol Dependence|June 11, 2008
A placebo-controlled trial of modafinil for nicotine dependenceRobert A Schnoll, E Paul Wileyto, Angela Pinto, et al.
Psychopharmacology|May 13, 2004
Changes in food reward following smoking cessation: a pharmacogenetic investigationCaryn Lerman, Wade Berrettini, Angela Pinto, et al.
The Journal of Pediatrics|May 19, 2009
Nocturnal enuresis: a suggestive endophenotype marker for a subgroup of inattentive attention-deficit/hyperactivity disorderJosephine Elia, Toshinobu Takeda, Rachel Deberardinis, et al.
Addiction Biology|February 9, 2011
Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohortTeresa R Franklin, Ze Wang, Yin Li, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 16, 2008
DAT genotype modulates brain and behavioral responses elicited by cigarette cuesTeresa R Franklin, Falk W Lohoff, Ze Wang, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 7, 2005
Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's diseaseSara M Bodner, Wade Berrettini, Vivianna van Deerlin, et al.
BMC Neuroscience|March 11, 2010
Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependenceJay Jin, Saranya Kittanakom, Victoria Wong, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|November 6, 2007
Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trialRiju Ray, Christopher Jepson, E Paul Wileyto, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 2005
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trialsCaryn Lerman, Christopher Jepson, E Paul Wileyto, et al.
Psychiatric Genetics|December 31, 2010
Genetic association of bipolar disorder with the β(3) nicotinic receptor subunit geneSarah M Hartz, Peng Lin, Howard J Edenberg, et al.
Drug and Alcohol Dependence|June 11, 2008
A placebo-controlled trial of modafinil for nicotine dependenceRobert A Schnoll, E Paul Wileyto, Angela Pinto, et al.
Psychopharmacology|May 13, 2004
Changes in food reward following smoking cessation: a pharmacogenetic investigationCaryn Lerman, Wade Berrettini, Angela Pinto, et al.
The Journal of Pediatrics|May 19, 2009
Nocturnal enuresis: a suggestive endophenotype marker for a subgroup of inattentive attention-deficit/hyperactivity disorderJosephine Elia, Toshinobu Takeda, Rachel Deberardinis, et al.
Addiction Biology|February 9, 2011
Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohortTeresa R Franklin, Ze Wang, Yin Li, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 16, 2008
DAT genotype modulates brain and behavioral responses elicited by cigarette cuesTeresa R Franklin, Falk W Lohoff, Ze Wang, et al.
Pageof 6